Electron Ionization Cross Section in relation to dosage of medicine-Antimicrobial drugs

Electron Ionization Cross Section in relation to dosage of medicine-Antimicrobial drugs By (1 S.Kavitha, 2 V.R. Murthy,,3 K.R.S. Samba Siva Rao)1(Research Scholar, Dept. of Biotechnology, Acharya Nagarjuna University, Guntur. Andhra Pradesh. India, 2(Prof.& Head, Dept. of Physics (P.G. Course), T.J.P.S. College, Guntur. Andhra Pradesh. India. (3 Prof. & Head, Dept. of Biotechnology, Acharya Nagarjuna University, Guntur. Andhra Pradesh. S.,*Corresponding author

Abstract

Physical parameters such as molecular polarizability, diamagnetic susceptibility, and molecular electron ionisation cross section are important parameters bearing some dependence on the dosage of the medicine through the electron transfer of the medicine in the process of diagnosis. Hence they are analysed and used in calculating the dosage of few anti-microbial drugs, in particular Quinolones. Data collected on Plasma protein binding Bioavailability, Half-life period and Log P show dependence on Q and is expressed in the form of a mathematical equation. The dosage thus calculated by above parameters has a good agreement with the suggested dosage values. For example Ciprofloxacin has the reported dosage value1.0grms/day against the calculated dosage value 0.849grams /day. In case of other drug Lomefloxacin, the calculated value is 0.394 grams /day against the reported value 0.4 grams /day. Similar observation was done in case of other quinolones compounds also. The present method enables a new approach in finding out the drug activity and is preferred to the highly theoretical approaches involving quantum mechanical methods.

Key words: Dosage, Half Life Period, Electron Ionisation cross section.

Introduction: The quinolones are potent synthetic chemotherapeutic, broad-spectrum antibiotics 1, 2. Since the introduction of Nalidixic acid in 1962 3, 4 several structural modifications have resulted in second, third and fourth generation antibiotics. With the recent introduction of agents such as Gatifloxacin and Moxifloxacin, the traditional gram-negative coverage of fluroquinolones has been expanded to include specific gram positive organisms5.Community acquired pneumonia is the sixth leading cause of death in the United States. Even with optimal therapy, this illness is associated with mortality rates of approximately 15 percent.6

Therapeutic uses of fluoroquinolones include the following: 1) For serious acute cases of pyelonephritis or bacterial prostatis, where the patient may need to be hospitalised, fluoroquinolones such as Ciprofloxacin, 7oflaxacin, lomefloxacin, enofloxacin, levofloxacin and gatifloxacin are recommended.8 2) Due to excellent penetration into prostatic tissue, norfloxacin, levofloxacin,ciprofloxacin and iflaxacinhave eradication rates of 67 to 91%.9,7 3) The U.S.Food and drug administrationhas labelled gatifloxacin, moxifloxacin, sparfloxacin and levofloxacin for use in the treatment of acute sinusitis.10For severe forms of community aqured pneumonia , the fluroquinolones are associated with improved treatment rates.11 4) In case of sexually transmitted diseases, a single dose of ciprofloxacin or ofloxacin is considered as alternative treatment in for example patients with pencillin allergy.12 5) Fluroquinolones in combination with other drugs such as ofloxacin plus metronidazole or Cefoxitin and ciprofloxacin plus clindamycin 7,10 are used to relieve pelvic inflammatory, Diabetic food infections etc. Norfloxacin or ciprofloxacin are used in the treatment of traveller’s diarrhea and certain other infections such as typhoid fever and Vibrio cholera. Adverse events: Although quinolones are well tolerated and relatively safe, certain adverse effects are 13, 14 common. Gastro intestinal and Central nervous system 15,16 effects are the most frequent adverse events occurring in 2 to 20 per cent of patients 17-22.Other adverse effects such as QTC prolongation, 23,24 hepatotoxicity, tendon rupture, cardiovascular toxicity, disturbed blood glucose levels 25,26 certain dermatologic effects etc.

Mechanism of fluoroquinolones: Fluoroquinolones interfere with bacterial DNA metabolism by the inhibition of two enzymes, Topoisomerase II (Syn. DNA gyrase) and Topoisomerase IV. In gram-negative organisms DNA gyrase is the primary target, where as in Gram -positive bacteria topoisomerase IV was recently found to be most affected. The function of DNA gyrase is to introduce supercoils into the linear DNA double helix, which results in the highly condensed three dimensional structure of the DNA usually present inside the cell. The function of topoisomerase IV is involved in the separation process of the DNA daughter chains after chromosome duplication. DNA gyrase and Topoisomerase IV have a very similar protein structure, each composed of two sub units(Gyr-A and gyr-B). The Gyr-A subunits of this enzyme were proposed to initially bind to the double stranded DNA helix. In an ATP-dependent process, described as intermediate gate opening step-, both DNA strands are leaved at certain 4 base pair staggered sites. The 5’ends of the DNA chain are thereby bound covalently to Tyrosine 122 residues with in the Gyr-A-subunits. Gyr-B-subunits are probably responsible for the ATP-dependent releasing process of the DNA. Two quinolones molecules self-assemble inside the pocket in dimer structure 27 and attach to the gyrase -DNA complex electrostatically, which stabilizes the intermediate stage of this reaction step. Permanent gaps in the DNA strands induce synthesis of repair enzymes (exonucleases) initiating uncoordinated repair process, which results in irreversible damage to the DNA and, finally, cell death. 28, 29

Methodology: A knowledge of Molecular polarizability, diamagnetic susceptibility, Molecular electron ionisation cross section reflects on transport mobility, activity and the vigour of the electron associate with the interaction of the medicine with the electrons released from host cell(or effected cell) of the body during the reaction .Hence an investigation of these properties leading to the dosage of the few anti-microbial drugs (Quinolones) is taken up in the present investigation. The above parameters are obtained through quantum mechanical approach of Lippincott, Bond Polorizability and Bond Refractivity of Le Fevre. The diamagnetic susceptibility for these systems is evaluated using Rao &Murthy’s method. The molecular electron ionization cross section is then evaluated from diamagnetic susceptibility using modified Kevan’s formula of Murthy et al. The electron ionization cross section along with the data of Protein binding, Bioavailability, Log P,& Half-life are taken from Wikipedia are used in the present investigation.30 The related work of drug dosage activity through molecular electron ionization cross- section and medical parameters like bioavailability, protein binding etc., has been reported by Murthy et al in a few medicinal systems. 31, 32, 33 The present paper deals with the evaluation of dosages of a few anti-microbial drugs (Quinolones). The information regarding the Molecular polarizability obtained by Lippincott method, Bond polarizability and Bond refractivity, diamagnetic susceptibility and molecular electron ionisation cross section was given in already accepted previous papers31, 32, 33, 34

?aP = 4nA/ao [(R2/4) + (1/2(CR)2)]2 x e-(XA-XB)2/4 (1)

?an = ? fj aj (2)

? 2 a- = n df ?2j/?j2 (3)

aM=1/3[?aP+? a n +? 2 a-] (4)

aM=?[3/4pN?](R8) (5)

aM= n1 a(c=c) + n2 a(c-c) +———– ——–=Ojnjaj (6)

?M = ? m s1aM (7)

Q (in 10-16cm2)=0.278n ?M ( 8)

Molecular polarizablility can be calculated by Lippincott method, Bond refraction method and Bond polarizability method. The aM by Lippincott method is evaluated with help of parallel component (?a?p), Perpendicular component (?2a-) and ?a?n .The parallel Component?a?p, is based on parameters i.e. A, CR, ao are taken from Lippincott35 are given in the equation(1).The values of bond lengths required for evaluating?a?p are taken from CRC Hand book of Physics and Chemistry.36 Similarly the perpendicular component is given in the equation(3).The electronegativity and atomic polarizability values are taken from the reference.36Thus calculated ?a?p, ?a?n and ?2a- are given in table I. Finally from these values aM is measured by the formula (4). Molecular polarizabilty obtained by other methods i.e Bond polarizablity and Bond refraction methods are given table II. The values needed to calculate the mean molecular polarizabilty -aM’ from Bond refractivities and Bond polarizabiltes are taken from Le Fevre37.and expressed in 10-25cm3.

The diamagnetic susceptibility -?M’ is calculated with the help of equation 7. The -aM’ values obtained by three methods i.e. Lippincott, Bond polarizablity and Bond refraction are inserted in the given equation which gives the ?M. The necessary data required for the calculation of -s’ Covalency factor taken from reference. 38

The covalency factor is calculated as s=[s1 1/n1. s2 1/n2——–s n 1/n8-]1/2 (9) s=e-(XA-XB)2/4 Where XA and XB are electronegativity of the bond A- B respectively and n1, n2 are the bond orders. Calculation of ?M is immediately followed by -Q’, Electron ionisation cross section which only needs the ?M value. The ?M and -Q’ values obtained by Lippincott Bond polarizablity and Bond refraction are shown in the table III. Practical approach for diamagnetic susceptibility through vibrational magnetometer technique is under progress. Of the three methods -Q’ obtained by Bond polarizablities are taken as standard because, this method is found to be sensitive to conformational changes than the other two methods. In table IV, the calculated values of Electron ionisation cross section -Q’ along with other medicinal parameters are given. These include Protein binding, Bioavailability, Log P and Half life period of some anti-microbial (Quinolones). The data required are taken from Wikepedia30. By calculating the -Q’, an attempt has been done in studying the activity of a drug and further its interaction with the target molecule. Finally with the help of the expression 10, dosage of antimicrobial drugs is calculated and compared with the reported dosage values taken from reference 30. The results are given in the table V.

=((Q/D)2/3LLogP) va/5 (10)

Where, Q – Electron ionisation cross section D-Dosage of the drug L- is the Half-life period Log P -Hydrophobicity a= (PB)(BA)/6ms

Where, m – the no.of unsaturation bonds PB -Protein binding BA-Bioavailabilty s- the Covalency factor

Results and Discussion: A keen observation of the dosages of the medicinal compounds calculated and reported show he following features. The calculated dosage of Prefloxacin is 0.825 grams per day against the reported dosage value 0.8grams per day. Similarly Lomefloxacin and Sparfloxacin has the calculated value 0.394 grams per day and 0.211 grams per day compared with the reported dosage value0.4 grams and 0.222grams per day. Good agreement regarding the dosage values were observed in case of other medicinal compounds also. An analytical approach on Q and medicinal parameters reveal some observations .Generally the medicinal compounds having similarity in their structure are analysed. In case of Quinolones (Antimicrobial drugs) ,Prefloxacin has the -Q’valuei.e3.03×10-16 cm2 less than Lomefloxacin Q value11. 27×10-16 cm2 But increased half-life period 8.6hrs than half life period of Lomefloxacin 3 to 5 hrs. Similarly for Nalidixic acid the half life is 1.1to2.5hrsless than the Ciprofloxacin h alflife period i.e.3 to 4 hrs. Compared to the -Q’ values of Nalidixic acid (12.23×10-16 cm2) and Norfloxacin (8.33×10-16 cm2). An attempt has been made in analysing the relation between Log P (Hydrophobicity) and ‘Q’ Electron ionization cross section. The hydrophobicity of Sparfloxacin is2.5 compared with the hydrophobicity value of Moxifloxcin 2.9 against the -Q’ value Sparfloxacin11.806×10-16 cm2 and Moxifloxacin 9.459 x10-16 cm2. Similar observations is done in case of Prefloxacin and Lomefloxacin. From the above data it is hypothesized that lower the hydrophobic nature of the drug higher may be the interaction of the drug with the target molecule and finally the activity of drug molecule i.e. Electron ionization cross section. Comparison of -Q’, Electron ionisation cross section value and the dosage value reflect some useful and supporting view to the above analysis. In case of Sparfloxacin Q value ( 11.806×10-16 cm2). The reported dosage value is0.22grams per day againt the lower Moxifloxacin Q value 9.459 x10-16 cm2 and higher dosage value 0.4grams per day respectively. Similarly Lomefloxacin (Q value11. 27×10-16 cm2) has 0.4grmas per day to Prefloxacin (Q’valueless than Lomefloxacin i.e3.03×10-16 cm2) dosage value 0.8 grams per day. Rigorous work is under study in order to understand the relation between -Q’, dosage and other medicinal parameters of other medicinal compounds.

A plausible explanation for this behaviour may be given as follows. An increase in electron transportation activity reflected by higher electron ionization cross section will tender the chemical reaction to be faster. Hence an incidence of electron from the donor to the place of malignity will make the process curing faster. Thus very little dosage of the medicine will be sufficient. A long continued impingement of the electrons on the malgn cells might develop saturation effects. Hence the life time of the drug for limited time suggested. Thus an increase in Q explains lower half life and lower dosage. A continued dosage of such medicine might result in undesirable toxic effects. Rigorous work is under study in order to understand the relation between -Q’, dosage and other medicinal parameters of other medicinal compounds.

Inference: The present method hints at study of important physical parameters like refractivity and electron ionization cross section through simple molecular structure. An elucidation of Q and its use with other medicinal parameters yield a new method of obtaining medicinal dosage. Thus the present method of arriving at medicinal dosage through physical parameters n, k ,Q give a novel approach of equation of dosage and looking at it from molecular level of interactions. This approach has the superiority over the already available sophisticated medicinal methods which involve highly theoretical quantum mechanical modelling, highly computive modelling or highly sophisticated physicochemical methods of drug analysis.

References 1)Nelson JM, Chiller TM, Powers JH, Angulo FJ (April 2007). “Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story”. Clin. Infect. Dis. 44 (7): 977-80. doi:10.1086/512369. PMID 17342653. http://www.journals.uchicago.edu/doi/abs/10.1086/512369?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov 2)Ivanov DV, Budanov SV (2006). “[Ciprofloxacin and antibacterial therapy of respiratory tract infections]” (in Russian). Antibiot. Khimioter. 51 (5): 29-37. PMID 17310788 3)Stacy J. Childs, MD (2000). “Safety of the Fluoroquinolone Antibiotics: Focus on Molecular Structure”. Infect Urol (USA: FQresearch) 13 (1): 3-10. 4)Catherine M.Oliphant,Pharm.D.,Gray M. Green, M.D.,-Quinolones: A Comprehensive Review-,Am Fam Physician. 2002 Feb1;65(3):455-465. 5)Turnidge J. Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs. 1999;58(suppl 2):29-36. 6)Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Disease Society of America. Clin Infect Dis. 2000;31:347-82. 7) Hooper D. Quinolones. In: Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett’s Principles and practice of infectious diseases. 5thed. Philadelphia: Churchill Livingstone, 2000:404-23. 8)Liu, H.; Mulholland, SG. (July 2005). “Appropriate antibiotic treatment of genitourinary infections in hospitalized patients.”. Am J Med 118 Suppl 7A: 14S-20S. doi:10.1016/j.amjmed.2005.05.009. PMID 15993673. 9)Sabbaj J, Hoagland VL, Cook T. Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men. Scand J Infect Dis 28 Suppl. 1986;48:48-53. 10)Hooper DC. New uses for new and old quinolones and the challenge of resistance. Clin Infect Dis. 2000;30:243-54. 11)Vardakas, KZ.; Siempos, II.; Grammatikos, A.; Athanassa, Z.; Korbila, IP.; Falagas, ME. (December 2008). “Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials.”. CMAJ 179 (12): 1269-77. doi:10.1503/cmaj.080358. PMID 19047608. PMC 2585120. http://www.cmaj.ca/cgi/content/full/179/12/1269 12)1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep. 1998;47(RR-1):1-111. 13)De Sarro A, De Sarro G (March 2001). “Adverse reactions to fluoroquinolones. an overview on mechanistic aspects” (PDF). Curr. Med. Chem. 8 (4): 371-84. PMID 11172695. http://www.fqresearch.org/pdf_files/cmc.pdf. 14)Owens RC, Ambrose PG (July 2005). “Antimicrobial safety: focus on fluoroquinolones”. Clin. Infect. Dis. 41 Suppl 2: S144-57. doi:10.1086/428055. PMID 15942881. 15)Owens RC, Ambrose PG (July 2005). “Antimicrobial safety: focus on fluoroquinolones”. Clin. Infect. Dis. 41 Suppl 2: S144-57. doi:10.1086/428055. PMID 15942881. http://www.journals.uchicago.edu/cgi-bin/resolve?CID34940

16) Iannini PB (June 2007). “The safety profile of moxifloxacin and other fluoroquinolones in special patient populations”. Curr Med Res Opin 23 (6): 1403-13. doi:10.1185/030079907X188099. PMID 17559736. 17)Hooper DC. Mode of action of fluoroquinolones. Drugs. 1999;58(suppl 2):6-10. 18)Hackbarth CJ, Chambers HF, Sande MA. Serumbactericidal activity of rifampin in combination with other antimicrobial agents againstStaphylococcus aureus. Antimicrob Agents Chemother. 1986;29:611-3. 19)Walker RC. The fluoroquinolones. Mayo Clin Proc. 1999;74:1030-7. 20). Lipsky BA, Baker CA. Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin Infect Dis. 1999;28:352-64. 21)Stahlmann R, Lode H. Toxicity of quinolones. Drugs. 1999;58(suppl 2):37-42. 22)Harrell RM. Fluoroquinolone-induced tendinopathy: what do we know?. South Med J. 1999;92:622-5. 23)Falagas ME, Rafailidis PI, Rosmarakis ES (April 2007). “Arrhythmias associated with fluoroquinolone therapy”. Int. J. Antimicrob. Agents 29 (4): 374-9. doi:10.1016/j.ijantimicag.2006.11.011. PMID 17241772. 24)Rubinstein E (2001). “History of quinolones and their side effects”. Chemotherapy 47 Suppl 3: 3-8; discussion 44-8. doi:10.1159/000057838. PMID 11549783. http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=che7c003 25)Mehlhorn AJ, Brown DA (November 2007). “Safety concerns with fluoroquinolones”. Ann Pharmacother 41 (11): 1859-66. doi:10.1345/aph.1K347. PMID 17911203. 26)Lewis RJ, Mohr JF (2008). “Dysglycaemias and fluoroquinolones”. Drug Saf 31 (4): 283-92. doi:10.2165/00002018-200831040-00002. PMID 18366239. 27)Hooper DC, Wolfson JS: Mechanism of quinolone action and bacterial killing, in Hooper DC, Wolfson JS (eds): Quinolone Antimicrobial Agents, ed 2. Washington DC, American Society for Microbiology: 53 – 75, 1993. 28)Shen LL: Quinolone – DNA interaction, in Hooper DC, Wolfson JS (eds): Quinolone Antimicrobial Agents, ed 2. Washington DC, American Society for Microbiology: 77 – 95, 1993. 29)Morais Cabral JH, Jackson AP, Smith CV, Shikotra N, Maxwell A, Liddington RC: Crystal structure of the breakage-reunion domain of DNA gyrase. Nature Vol 388 / 28: 903 – 906, 1997. 30)http://www.winkipedia.com 31)Murthy, V.R.& Venkata Raghuram D, Drug, dosage, activity, Studies of antimalarials by Physical methods-II, Bonformation 2(1); 12-16(2007). 32)Murthy, V.R.& Venkata Raghuram D and Murthy, P.N.romanian J.Phy. 17, 207, 2007. 33)Murthy, V.R.& Venkata Raghuram D and Murthy, P.N. Proce.National Seminar recent trends in Biomedical Physics. Guntur.(India) p.122-132. 34)V.R. Murthy, S.Kavitha, K.R.S. Samba Siva Rao,- Drug, Dosage Studies of A Few Centrally Acting Muscle Relaxants- http://www.amazines.com/article_detail.cfm?articleid=2205851. 35) Rao. B.P., Murthy,V.R.,-Curr.Sci.-,1972, 41, No:1

36) David, R. Lide, CRC Hand Book of Chemistry and Physics, National Institute of Standard Technology, CRC Press LLC, London, (2004). 37)Molecular Refractivity and Polarizability by R.J.W. Le Fevr, Advances in Physical Organic Chemistry 3,1-90,(1965). 38) A Hand Book Of Chemistry and Physics ,CNR Rao, Mahanthy & others, Affliated East &West Press Limited, New Delhi,(1967).

TABLE-1 Molecular Polarizabilities of Anti-microbial drugs(Quinolones) by Lippincott method in 10-25cm3

S.NoName of the drug?a?p?a?n?2a- 1Nalidixic acid469.19117.784231.208 2Norfloxacin645.04924.96346.985 3Ciprofloxacin691.86624.956272.072 4Sparfloxacin768.94024.956272.072 5Moxifloxacin862.9924.703329.746 6Prefloxacin680.24320.756306.652 7Lomefloxacin687.93520.756269.383

TABLE-II Molecular Polarozablities (aM) in 10-25cm3 S. NoName of the drugaM by Lippincott methodaM by Bond PolarizablityaM by Bond Refraction 1Nalidixic acid231.208266.244247.319 2Norfloxacin315.907346.985333.101 3Ciprofloxacin329.631366.252342.97 4Sparfloxacin385.709383.183378.339 5Moxifloxacin405.814423.115421.671 6Prefloxacin335.894354.352352.635 7Lomefloxacin326.025347.852347.166

TABLE-III The Diamagnetic Susceptibilities (in 106CGS units) and Molecular Electron Ionisation cross section (in10-16cm2)of certain Anti-microbial drugs(Quinolones) ? M in 106CGS units Qin10-16cm2 S.NoName of the drugByByByByByBy LippincottBond PolarizabilityBondLippincottBond PolarizabilityBond Refraction method Refractionmethod 1Nalidixic acid56.41764.96760.3411.43313.16612.23 2Norfloxacin38.98942.82541.1127.9028.6798.332 3Ciprofloxacin65.82373.14668.49512.3414.82413.881 4Sparfloxacin59.39959.10158.25612.03811.97811.806 5Moxifloxacin44.9246.83546.6779.1049.4929.46 6Prefloxacin14.25415.03814.9642.8893.0483.033 7Lomefloxacin53.85155.74855.63810.91411.29511.276

TABLE-IV Electron Ionisation cross section (in10-16cm2 ) and other medicinal parameters

S.NoName of the drugQ PB BALog PHalf Life(hrs) 1Nalidixic acid12.23093962.11.1-2.51.383 2Norfloxacin8.33215502.13-41.1383 3Ciprofloxacin13.88130502.53-51.176 4Sparfloxacin11.80650502.5201.272 5Moxifloxacin9.45986-92402.9121.477 6Prefloxacin3.033251002.48.61.450 7Lomefloxacin11.2760.725502.13-51.335

TABLE-V Drug dosage (in grams/day) S. NoName of the druga’Calculated dosages grams/dayReported dosages grams/day 1Nalidixic acid0.0951.3834.0334.0 2Norfloxacin0.0091.1380.6510.80 3Ciprofloxacin0.0131.1790.8491.0 4Sparfloxacin0.0261.2730.2110.222 5Moxifloxacin0.0491.4750.4090.40 6Prefloxacin0.0691.4490.8250.8 7Lomefloxacin0.0371.3350.3940.4

Honey, the Medicine of Choice for Many

After being forgotten as a viable treatment source, honey is being rediscovered as a preferred method of healing a wide spectrum of health conditions, both internally and topically on the skin.

Many cultures have embraced the concept of using honey as a medicine. Cave paintings in Spain dating as far back as 7000 B.C. show men collecting honey from a bee colony. The medicinal properties of honey have been known since ancient times. A Sumerian tablet from around 3000 B.C. prescribes honey to treat an infected skin ulcer. Papyrus writings dated 2000 B.C. from Egypt prescribes honey to treat a gaping wound of the eyebrow. Before modern-day medicine as we know it was invented, honey was used for its medicinal properties.

The ancient Egyptians, Assyrians, Chinese, Greeks and Romans all used honey to treat a variety of ailments. Around 350 B.C., Aristotle wrote about honey being used to treat wounds and sore eyes. Muhammad, the Muslim prophet, recommended honey to treat diarrhea, and the Koran mentions the curative properties of honey.

Once the therapeutic value of honey was discovered, it was widely used regularly as for medical purposes. Ancient cultures accepted the use of honey as a medicine. The medicinal benefits of honey were passed on from generation to generation, and today honey is a popular medicine in many parts of the world, with a notable exception of the United States.

Why not the U.S.? Many in the American medical community still view honey as a food item and well outside the mainstream of medicine. Many U.S. doctors are reluctant to even experiment with honey for fear of being ostracized by their peers. However, European and other countries have a long history of honey and its medicinal benefits.

One U.S. company has made major strides in bringing the use of honey as a medicine back into the limelight. Honeymark International, a New York-based company uses a particular type of honey from New Zealand known as Manuka Honey in its products. Even though all types of honey have medicinal qualities, Manuka Honey seems to have more than others.

When using Manuka Honey to treat internal ailments, such as stomach ulcers, strep throat, acid reflux, etc., ingesting it is easy because many of us enjoy eating honey, and it tastes better than medicine. However, using Manuka Honey topically on the skin can be somewhat of a sticky mess. Honeymark has developed skin care products containing active Manuka Honey as a natural healing agent to avoid this inconvenience. Honeymark’s cream-based products and lotions make it easy to take advantages of the health benefits of Manuka Honey.

Honeymark offers a line of Manuka Honey skin care products to treat conditions such as infected wounds, burns, eczema, ringworm, acne, arthritis and even wrinkles. Manuka Honey has very powerful antibacterial properties that make it ideal for eliminating infectious bacteria that are responsible for many health concerns. One of Manuka Honey’s greatest accolades is its ability to health MRSA Staph infections, where antibiotics and other traditional forms of medicine have failed.

Pulsar Probe – Revolutionizing the World of Alternative and Conventional Medicine

Quantum cold laser therapy is quickly becoming the prime choice in alternative treatments. With the power to balance the body, pulsar probe technology can be the best medical intervention you can experience. Scalar lasers, a revolutionary healing device that uses advanced pulsar probe technology, can be your best ally in the prevention and treatment of various medical conditions that keeps you from enjoying life. This alternative therapy has been recommended primarily for pain relief and pain management but it does offer so much more.

Since the laser has been discovered, there has been a continuous objective to find out how else it can benefit mankind. Here are just some of the findings associated with pulsar probe and its effect on an individual’s body.

Pains in the shoulders due to excessive and often repetitive movements significantly decrease with the use of this treatment. Additionally, there were no side effects reported. For a device that is seemingly more affordable that conventional medical therapies, the positive effects of pulsar probe therapy definitely outweighs its cost.

Aside from shoulder pain, one of the most common complaints in the workplace – the carpal tunnel syndrome or disorder -is also a condition that can benefit positively from low-level laser light therapy or cold laser. This repetitive stress injury that concerns the carpal tunnel and the spine is dealt with more effectively by pulsar probe than by traditional practices such as physical therapy and surgery.

There is a dramatic and almost immediate increase in immunity both for children and adults with continued quantum laser treatment. This may be due to the ability of pulsar probe to target cells and stimulate these to be more active and healthy promoting rejuvenation in both inter and intra cellular processes.

Pulsar probe technology is also used for aesthetic treatments on the surface of the skin. This is because cells seem to heal better and faster when treated by low-intensity laser. Laser therapy is then recommended for the treatment of wounds and even burns in some studies. Also, laser light therapy is also used for non-invasive facelifts.

Arthritis, a common ailment especially for older men and women is another condition that can be alleviated with the use o pulsar probe technology. Because low level laser light stimulates cell regeneration and can also help in balancing blood flow, pain and swelling are relieved. Additionally, this technology has also been seen to catalyze the release of endorphins- a primary enzyme that helps in pain relief.

It has also been claimed that pulsar probe technology can help in the detoxification of the body. These may be related to the consideration that cells are healthier thus more adept at improving the different cleansing functions of the body.

There are so many more possible conditions that pulsar probe technology can help in. What is more is that pulsar technology has paved the way for the introduction of scaled laser therapy devices that can deliver different combinations of wavelengths and frequencies to different ailing parts of the body. Learn more about this wonderful healing laser today and make your life better.

The Pulsar Probe is indeed revolutionizing the world of alternative and conventional medicine with it’s 21st century approach, methods and equipment. You can keep yourself away from the clutter of the 21st century with a shoe storage cabinet which is modern in every way.

Acupuncture an Alternative Medicine

Acupuncture is often associated with pain control; in the hands of a well-trained practitioner, it has much broader applications. Acupuncture is a part of the health care system of China that can be traced back at least 2,500 years. The general theory of acupuncture is based on the premise that there are patterns of energy flow (Qi) through the body that are essential for health. Disruptions of this flow are believed to be responsible for disease. The goal of this procedure is to restore the well-being and the health of the individual. While it may seem strange, acupuncture uses a method of inserting needles into specific points in the body. It should only be performed by a skilled individual, one that has received training in the. It is a method of encouraging the body to promote natural healing and to improve functioning. Acupuncture can be effective as the only treatment used, or as the support or adjunct to other medical treatment forms in many medical and surgical disorders. One should always plan their activities so that after the treatment one can get some rest. This is especially important for the first few visits. Do not eat an unusually large meal immediately before or after the treatment.

With increased globalization and exchange of views and other parameters, the system of medicine also attempts to enter into the others territories. It is an ongoing process, which results in giving world class treating mechanisms and ultimately results in better way of healing. As there are many cases that represent the audacity of the claim of treating by one system of medicine establishing itself as superior, yet there are no guarantees that a particular medicine system will eventually succeed in giving relief to the patient. However, there are attempts that go on in justifying the superiority of a particular medicine system and it applies to all the healing systems of the world. In fact, it is primarily the result of enhanced globalization.

Some of the people on the western side of the fence think that Chinese Medicine is confined to magic and associate it with being hocus-pocus. They see it primitive and since the basis of Chinese Medicine owes its origins to herbs or acupuncture, it is largely related to one of yet another term, placebo effect. Chinese Medicine is largely taken upon as non-working when it comes to serious cure and genuine diseases or illnesses. Moreover, Chinese Medicine is taken as ancient leaning towards spiritualism, and more taken as falling in the category of religious healing practices.

However, the fact of the matter is entirely different. Chinese Medicine is actually coherent and independent system of thought and practice that took quite a long time to evolve and reach the current stage. Chinese Medicine approaches the human body and attempts to restore it with an progress understanding and curing skills. That is where it is gaining immense popularity not only in the areas where it is already established but also in the far-flung world regions.

The Power of Natural Alternative Medicine – Part 1

The doctor of the future will give no medicine, but will interest his patients in the care of the human body, in diet and in the cause and prevention of disease.”…Thomas Edison, 1902

We have many different options for healthcare today, but the focus of this article will be on biologically based treatments and prevention. The National Center for Complementary and Alternative Medicine (NCCAM) defines the scope of biologically based practices to include, but is not limited to, botanicals, animal-derived extracts, vitamins, minerals, fatty acids, amino acids, proteins, prebiotics and probiotics, whole diets, and functional foods.

But first, lets take a look at the different philosophies of healthcare practiced today. Allopathic, alternative, complementary, integrativewhat does it all mean? Each includes many different kinds of therapies, and although alternative, complementary and integrative are sometimes used interchangeably, the general focus of each is different.

Allopathic medicine focuses on disease and the treatment of the physical body with drugs and surgery. These are conventional physicians with the title of M.D. that are universally recognized as having a medical degree.

Alternative medicine includes those therapies not generally recommended by allopathic physicians. It includes Energy Medicine, Ethnomedicine, Chiropractic, Acupuncture, Homeopathic Medicine, Botanical or Herbal Medicine, Biomolecular Medicine, Manual Medicine, Spiritual Medicine.

Complementary medicine includes therapies used by both alternative and allopathic physicians. It includes Exercise Medicine, Environmental Medicine, Social Medicine, and Nutritional Medicine.

Integrative medicine is the attempt to integrate the many philosophies of medicine, allopathic, complementary, and alternative, to treat the whole person, physical, emotional, spiritual, and intellectual.1

Many people are hesitant about trusting their healthcare to anyone other than an allopathic physician. But did you know that Naturopathic Medical Doctors are the only physicians who receive complete training in conventional medicine as well as natural medicine? Licensed naturopathic medical doctors (N.M.D. /N.D.) attend a four-year graduate level naturopathic medical school where they are educated in all of the same basic sciences as a conventional M.D. In addition to this training, they are extensively educated in the philosophy and implementation of safe and effective natural therapeutics with a strong emphasis on disease prevention. Unfortunately, some states do not yet offer licensing for Naturopathic Doctors.

Allopathic physicians and pharmaceutical drugs are, and always will be, necessary for acute, emergency medical care and trauma, as well as for conditions that cannot be controlled with lifestyle changes, good nutrition and supplements. But many conditions can be prevented and controlled with lifestyle changes and biologically based medicine. Just as many pharmaceutical drugs can interact with other drugs, some biologically based supplements may interact with drugs and cause side effects, so a healthcare provider should always be consulted before adding supplements to the diet. In some cases, alternative therapy may actually have beneficial synergistic effects in conjunction with existing medical therapy, even when not feasible as a replacement.

Biologically based medicine is not new. It was practiced for thousands of years before pharmaceutical companies began manufacturing the first synthetic drugs. In addition, many of the pharmaceutical preparations used around the world are based on plants. As late as the 1930’s, the formulation of about 80% of synthetic pharmaceutical drugs began with a natural compound. Today, about 25% of prescription drugs contain active ingredients derived from plants.

The United States has the most advanced medical system in the world, yet the population is increasingly turning to natural healing methods. However, the U.S. still lags behind world stats. A survey of 31,000 U.S. adults conducted by the National Center for Health Statistics in 2004 showed that 35 percent use some form of complementary and alternative medicine. Today, the World Health Organization estimates that herbal medicine is still the primary source of health care for approximately 80 percent of the worlds population.

Chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the United States. These diseases and other chronic diseases such as obesity, depression, metabolic and digestive disorders, rheumatoid arthritis, osteoporosis, and fibroids, account for 7 of every 10 deaths and affect the quality of life of 90 million Americans. Chronic diseases are among the most prevalent and most costly, yet they are the most preventable.

Conventional physicians treat chronic diseases with expensive pharmaceuticals that may temporarily relieve the painful or uncomfortable symptoms, but the drugs do nothing to resolve the underlying cause, and may actually cause other side effects and serious problems. Because nutrition affects our immune system, organ function, hormonal balance and cellular metabolism, many of these chronic conditions and diseases can be traced to a nutrition deficiency. When the deficiency is not corrected, symptoms begin to appear and eventually lead to disease and premature aging.

Many pharmaceuticals can effectively be replaced with multivitamin supplements, botanicals, amino acids, prebiotics and probiotics, fresh foods and functional foods for both prevention and treatment. Because herbs work synergistically, combinations of herbs with similar properties enhance the properties of each. This is why choosing a product containing a combination of different herbs is usually more effective than choosing individual selections. An example of this is the combination of valerian, passion flower and hops to promote relaxation and restful sleep. All three have a relaxing effect on the body. Valerian relaxes muscle tension, while hops relaxes the nervous system, and passiflora acts as a sedative. Popular alternative medicine company Melaleuca even offers a product called RestEZ, a supplement that contains all three natural sleep enhancers: valerian, passion flower and hops.

In part two of The Power of Natural Alternative Medicine we will discuss the regulation of nutritional supplements and little known history of natural medicine. This publication is courtesy of RMBarry Publications who publish various books about Melaleuca Products.